본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Antibody System

[Antibodysystem] Eldelumab ELISA Kit

Cat-No. KDC01901



AntibodySystem는 Primary Antibody Biosimilar - Research Grade 

제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다. 





제품 설명 


Eldelumab ELISA Kit

 



제품 번호


KDC01901




제품 특징

Catalog No.

KDC01901

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Detection method

Colorimetric

Precision


CV<20%


Sample type

Plasma, Serum

Assay type

Quantitative

Sensitivity

0.156 μg/ml

Range

0.31-5 μg/mL

Recovery

80-120%

Specifications

Eldelumab

Alternative Names

BMS-936557, MDX-1100, CAS: 946414-98-8

Background

Eldelumab (alternative identifier BMS-936557) is a fully human monoclonal antibody (type IgG1 kappa) that targets chemokine (CXC motif) ligand 10 (CXCL10)/Interferon-γ-inducible protein-10 (IP-10). This drug was developed by Bristol-Myers Squibb and Medarex and designed for the treatment of Crohn's disease and ulcerative colitis. To date, eldelumab has been investigated as an induction and maintenance therapy in active Crohn's disease, and its induction treatment demonstrated trends towards clinical and endoscopic efficacy with no new safety signal in a phase IIa study. Meanwhile, inhibiting IP-10 activity through the use of the monoclonal antibody, eldelumab, demonstrated efficacy in patients who achieved high serum concentrations in this phase II, randomized, controlled, proof-of-concept study of moderate-to-severe ulcerative colitis.

Shipping

2-8 ℃

Note

For Research Use Only.




AntibodySystem의 모든 제품들을 만나 보세요!  


Products

Recombinant Protein

Antibody

Assay Kit

Research Biosimilar

Enzyme

Trending Product

Super-Affinity Antibody

Cell Lysates



Antibodysystem - Official Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"